Changes to This Summary (03/29/2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added Kreissman et al. as reference 1.
Added text to state that one study demonstrated that some killer immunoglobulin-like receptor mismatching combinations can lead to decreased relapse after acute myeloid leukemia HCT without T-cell depletion (cited Venstrom et al. as reference 48).
Added Corbacioglu et al. as reference 12.
This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.